Innovative treatments for
STAY NOTIFIED ABOUT MEDIPURE'S DEVELOPMENTS
1 (877) 264-0345
Leadership & Management
Scientific Advisory Board
Physicians & Patients
You are here
Nov 01, 2018
The Medipure Newsletter - Q2-3 2018 Edition
Read our Q2-3 2018 Edition of the Company Newsletter
Oct 29, 2018
Medipure Announces Director of Operations for Croatian Subsidiary
Medipure announced the appointment of Dr. Dubravko Kičić as Director of Operations for its Croatian subsidiary.
Sep 19, 2018
Medipure Receives Health Canada Approval for Level 6 Dealer's Licence
On August 24, 2018, the Office of Controlled Substances (OCS), Health Canada granted Medipure Pharmaceuticals Inc. a full Level 6 Dealer's License for Controlled Substances pursuant to the Controlled Drugs and Substances Act.
Aug 31, 2018
Medipure Expands to Croatia
Medipure Holdings Inc. is taking another step to advance its research and development by creating a subsidiary, Medipure d.o.o., in Croatia.
May 31, 2018
Medipure Expands to India
Medipure Holdings Inc. has taken the next step to advance its research and development by creating a subsidiary, Medipure LifeSciences India (MLSI) Pvt Ltd.
Apr 27, 2018
Medipure Pharmaceuticals Inc. Announces Appointment of Dr. Safwat Rabea as Research Scientist - Medicinal Chemistry
The latest hiring at Medipure Pharmaceuticals Inc.
Jan 30, 2018
Could Canada become a global health research hub?
Medipure CEO Boris Weiss interviewed by BC Business magazine
Red Rocket Creative Strategies
Back to Top